Diabetic dyslipidaemia

Diabetes, Obesity and Metabolism

Volumn 2, Issue SUPPL. 1, 2000, Pages

  Betteridge, D John ^a,b  

^a ROYAL FREE AND UNIVERSITY COLLEGE MEDICAL SCHOOL   (United Kingdom)

^b MIDDLESEX HOSPITAL   (United Kingdom)

Author keywords

Coronary heart disease; Dyslipidaemia; High density lipoprotein; Low density lipoprotein; Triglyceride; Type 2 diabetes

Indexed keywords

ANION EXCHANGE RESIN; ANTILIPEMIC AGENT; FIBRIC ACID DERIVATIVE; FISH OIL; GEMFIBROZIL; GLUCOSE; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; INSULIN; LIPID; NICOTINIC ACID; PRAVASTATIN; TRIACYLGLYCEROL;

BLOOD GLUCOSE MONITORING; CLINICAL TRIAL; DIET THERAPY; DYSLIPIDEMIA; EXERCISE; HUMAN; HYPERTRIGLYCERIDEMIA; INSULIN RESISTANCE; ISCHEMIC HEART DISEASE; LIFESTYLE; METABOLIC DISORDER; NON INSULIN DEPENDENT DIABETES MELLITUS; PATHOGENESIS; PRESCRIPTION; REVIEW; RISK ASSESSMENT; RISK MANAGEMENT; VASCULAR DISEASE;

EID: 0034522940     PISSN: 14628902     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1463-1326.2000.00021.x     Document Type: Review

References (52)

1. The St Vincent declaration: Diabetes care and research in Europe
2. Mechanisms determining course and outcome of diabetic patients who have had acute myocardial infarction
3. Angiographic findings and outcome in diabetic patients treated with thrombolytic therapy for acute myocardial infarction: The GUSTO-I experience
4. Long-term prognosis after myocardial infarction in men with diabetes
5. Mortality, place and mode of death and reinfarction during a period of 5 years after acute myocardial infarction in diabetic and non-diabetic patients
6. Increased restenosis in diabetes mellitus after coronary interventions is due to exaggerated intimal hyperplasia. A serial intravascular ultrasound study
7. Coronary artery disease and coronary artery bypass grafting in diabetic patients aged > or = 65 years (report from the Coronary Artery Surgery Study [CASS] Registry)
8. Comparison of coronary bypass surgery with angioplasty in patients with multivessel disease
9. Restenosis rates in diabetic patients: A comparison of coronary stenting and balloon angioplasty in native coronary vessels
10. Diabetes mellitus, a predictor of morbidity and mortality in the Studies of Left Ventricular Dysfunction (SOLVD) Trials and Registry
11. Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33)
12. Epidemiology of macrovascular disease in diabetes
13. Type 2 diabetic subjects without prior myocardial infarction are at the same risk of coronary events as non-diabetic subjects with prior myocardial infarction
14. Direct and indirect costs of diabetes in the United States in 1987
15. Risk factors for coronary artery disease in non-insulin dependent diabetes mellitus: United Kingdom Prospective Diabetes Study (UKPDS 23)
16. Cholesterol lowering with simvastatin improves prognosis of diabetic patients with coronary heart disease. A subgroup analysis of the Scandinavian Simvastatin Survival Study (4S)
17. Diabetes and atherosclerosis: An epidemiologic view
18. Cardiovascular events and their reduction with pravastatin in diabetic and glucose-intolerant myocardial infarction survivors with average cholesterol levels: Subgroup analyses in the cholesterol and recurrent events (CARE) trial
19. Lipids and lipoproteins as coronary risk factors in non-insulin-dependent diabetes mellitus
20. Diabetic dyslipidemia and its therapy
21. Diabetes, other risk factors, and 12-yr cardiovascular mortality for men screened in the Multiple Risk Factor Intervention Trial
22. LDL heterogeneity: Implications for atherogenicity in insulin resistance and NIDDM
23. Dense low density lipoproteins and coronary artery disease
24. Oxidative modification of LDL and atherogenesis
25. Epitopes close to the apolipoprotein B low density lipoprotein receptor-binding site are modified by advanced glycation end products
26. Triglyceride: The forgotten risk factor
27. Triglyceride as a risk factor for coronary artery disease
28. Plasma triglyceride level is a risk factor for cardiovascular disease independent of high-density lipoprotein cholesterol level: A meta-analysis of population-based prospective studies
29. Triglyceride concentration and ischemic heart disease: An eight-year follow-up in the Copenhagen Male Study
30. Triglycerides and coronary heart disease - Has epidemiology given us the right answer?
31. The atherogenic significance of an elevated plasma triglyceride level
32. Effect of gender, age, and lipid status on low density lipoprotein subfraction distribution
33. Diabetic dyslipidemia: Basic mechanisms underlying the common hypertriglyceridemia and low HDL cholesterol levels
34. Triglycerides and atherogenic lipoproteins: Rationale for lipid management
35. Postprandial lipoproteins and progression of coronary atherosclerosis
36. Post-prandial lipid metabolism and beta-cell function in non-insulin-dependent (type 2) diabetes mellitus after a mixed meal with a high fat content
37. Diabetic dyslipidaemia: Implications for vascular risk
38. Management of dyslipidemia in adults with diabetes
39. Management of dyslipidemia in adults with diabetes
40. Optimum dietary approach in Type 2 diabetes
41. Comparison of statins in hypertriglyceridemia
42. Randomised trial of cholesterol lowering in 4444 patients with coronary heart disease
43. The effect of pravastatin on coronary events after myocardial infarction in patients with average cholesterol levels
44. Report of the expert committee on the diagnosis and classification of diabetes mellitus
45. Reduced coronary events in simvastatin-treated patients with coronary heart disease and diabetes or impaired fasting glucose levels
46. Prevention of cardiovascular events and death with pravastatin in patients with coronary heart disease and a broad range of initial cholesterol levels
47. Prevention of coronary heart disease with pravastatin in men with hypercholesterolemia
48. Primary prevention of acute coronary events with lovastatin in men and women with average cholesterol levels: Results of AFCAPS/TexCAPS
49. Gemfibrozil for the secondary prevention of coronary heart disease in men with low levels of high-density lipoprotein cholesterol
50. Pathophysiology of insulin resistance in human disease
51. Coronary heart disease incidence in NIDDM patients in the Helsinki Heart Study
52. Prevention of coronary heart disease in clinical practice: Recommendations of the Second Joint Task Force of European and other Societies on Coronary Prevention